Disease Markets Crash

When technology allowed the financial sector to make transactions that exceeded the speed of the underlying business, the sector popped, detached, and began operating in the abstract. In this vacuum, the rules changed. Meanwhile, manufacturing, housing, and other real-world business were still tied to finance and dependent on its rhythm and flow. The results were utterly destabilizing and disruptive.

What happens when this happens in other sectors? What happens when the field of medicine can predict and model the structure of diseases that don’t yet exist? When, to remain competitive, they produce vaccines to combat them and the pathogens to test them? Or more profoundly, when they offer the genetic alterations to reduce the odds of a mutation that has never occurred in anyone?

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.